Gene · 8202
Papers3,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncogenic potential of ATAD2 in stomach cancer and insights into the protein-protein interactions at its AAA + ATPase domain and bromodomain. | J Biomol Struct Dyn | 2022 | 33438526 | PubTator, text mining | PubMed |
| Pharmacological Rationale for Targeting IL-17 in Asthma. | Front Allergy | 2021 | 35387016 | PubTator, text mining | PubMed |
| DNA Damage and Activation of cGAS/STING Pathway Induce Tumor Microenvironment Remodeling. | Front Cell Dev Biol | 2021 | 35265630 | PubTator, text mining | PubMed |
| TTN/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients. | Transl Cancer Res | 2021 | 35116455 | PubTator, text mining | PubMed |
| Identification of key genes involved in tamoxifen-resistant breast cancer using bioinformatics analysis. | Transl Cancer Res | 2021 | 35116374 | PubTator, text mining | PubMed |
| Identification of a novel circRNA, hsa_circ_0065898, that regulates tumor growth in cervical squamous cell carcinoma. | Transl Cancer Res | 2021 | 35116238 | PubTator, text mining | PubMed |
| The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: Evidence From lncRNA-miRNA-mRNA Network Analysis. | Front Oncol | 2021 | 35111675 | PubTator, text mining | PubMed |
| The Role of Circular RNAs in the Drug Resistance of Cancers. | Front Oncol | 2021 | 35070998 | PubTator, text mining | PubMed |
| Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets. | Pharmaceutics | 2021 | 35056904 | PubTator, text mining | PubMed |
| Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing. | Cells | 2021 | 35011583 | PubTator, text mining | PubMed |
| Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides. | Molecules | 2021 | 35011278 | PubTator, text mining | PubMed |
| Advancing Smart Home Awareness-A Conceptual Computational Modelling Framework for the Execution of Daily Activities of People with Alzheimer's Disease. | Sensors (Basel) | 2021 | 35009709 | PubTator, text mining | PubMed |
| A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer. | Int J Mol Sci | 2021 | 35008645 | PubTator, text mining | PubMed |
| Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer. | Front Mol Biosci | 2021 | 34977151 | PubTator, text mining | PubMed |
| A Storytelling Robot Managing Persuasive and Ethical Stances via ACT-R: An Exploratory Study. | Int J Soc Robot | 2021 | 34956417 | PubTator, text mining | PubMed |
| Autism-Related Transcription Factors Underlying the Sex-Specific Effects of Prenatal Bisphenol A Exposure on Transcriptome-Interactome Profiles in the Offspring Prefrontal Cortex. | Int J Mol Sci | 2021 | 34947998 | PubTator, text mining | PubMed |
| MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets. | Biomedicines | 2021 | 34944633 | PubTator, text mining | PubMed |
| Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health. | Antioxidants (Basel) | 2021 | 34942997 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Inhibitor of Apoptosis Protein Expression and Prognostic Significance in Non-Small Cell Lung Cancer. | Front Genet | 2021 | 34925455 | PubTator, text mining | PubMed |
| Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines. | Front Immunol | 2021 | 34917077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8202/papers?page=32